통합검색
내가 찾은 검색어
'entecavir' 에 대한 통합검색결과 46건입니다.
한빛사46건
-
Baseline viral load and on-treatment hepatocellular carcinoma risk in chronic hepatitis B: A multinational cohort study
- Clin. Gastroenterol. Hepatol. Aug 22 2024, S1542-3565(24)00763-8 | https://doi.org/10.1016/j.cgh.2024.07.031
- 2024.08
- 의약학
-
Tenofovir is associated with a better prognosis than entecavir for hepatitis B virus-related hepatocellular carcinoma
- Clin. Gastroenterol. Hepatol. Jul 30 2024, S1542-3565(24)00684-0 | https://doi.org/10.1016/j.cgh.2024.07.013
- 2024.07
- 의약학
-
Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study
- Clin. Mol. Hepatol. Jul 2024, 30 (3) | https://doi.org/10.3350/cmh.2024.0055
- 2024.07
- 의약학
-
Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B
- J. Med. Virol. 28 June 2024 | https://doi.org/10.1002/jmv.29760
- 2024.06
- 의약학
-
Chronic Hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-Positive patients
- Hepatology Jan 24 2024, | https://doi.org/10.1097/HEP.0000000000000752
- 2024.01
- 의약학
-
Sex differences in treatment response to nucleos(t)ide therapy in chronic hepatitis B: a multicenter longitudinal study.
- Clin. Gastroenterol. Hepatol. Sep 19 2023, S1542-3565(23)00713-9 | https://doi.org/10.1016/j.cgh.2023.09.002
- 2023.09
- 의약학
-
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.
- J. Hepatol. Sep 19 2023, S0168-8278(23)05096-1 | https://doi.org/10.1016/j.jhep.2023.09.011
- 2023.09
- 의약학
-
Personalized Antiviral Drug Selection in Chronic Hepatitis B Patients Using a Machine Learning Model: A Multinational Study
- Am. J. Gastroenterol. 2023 Mar 7 | DOI: 10.14309/ajg.0000000000002234
- 2023.03
- 의약학
-
Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-ana
- J. Hepatol. 2022 Dec 23;S0168-8278(22)03459-6 | https://doi.org/10.1016/j.jhep.2022.12.007
- 2022.12
- 의약학
-
Hepatitis B virus treatment and hepatocellular carcinoma-controversies and approaches to consensus
- Liver Cancer December 2022;11(6):497-510 | https://doi.org/10.1159/000525518
- 2022.12
- 의약학
-
ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis
- Clin. Gastroenterol. Hepatol. 2022 Nov 11;S1542-3565(22)01050-3 | https://doi.org/10.1016/j.cgh.2022.10.035
- 2022.11
- 의약학
-
Tenofovir is Associated With Higher Risk of Kidney Function Decline Than Entecavir in Patients With Chronic Hepatitis B
- Clin. Gastroenterol. Hepatol. 2022 Apr;20(4):956-958.e2 | https://doi.org/10.1016/j.cgh.2021.05.032
- 2022.04
- 의약학
-
Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate
- Clin. Gastroenterol. Hepatol. Volume 20, Issue 2, February 2022, Pages 427-437.e5 | https://doi.org/10.1016/j.cgh.2021.04.045
- 2022.02
- 의약학
-
Effect of particle size on in vivo performances of long-acting injectable drug suspension
- J. Control. Release Available online 11 December 2021 | https://doi.org/10.1016/j.jconrel.2021.12.011
- 2021.12
-
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
- J. Hepatol. Available online 2 October 2021 | https://doi.org/10.1016/j.jhep.2021.09.025
- 2021.10
- 의약학
-
Methodological Challenges in Meta-Analysis to Assess the Risk of Hepatocellular Carcinoma Across Chronic Hepatitis B Treatments
- J. Hepatol. Available online 27 September 2021 | https://doi.org/10.1016/j.jhep.2021.09.017
- 2021.09
- 의약학
-
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients with Chronic Hepatitis B
- Clin. Gastroenterol. Hepatol. Available online 6 September 2021 | https://doi.org/10.1016/j.cgh.2021.09.001
- 2021.09
- 의약학
-
Prediction of Hepatocellular Carcinoma by On-Therapy Response of Noninvasive Fibrosis Markers in Chronic Hepatitis B
- Am. J. Gastroenterol. March 10, 2021 - Volume Publish Ahead of Print - Issue | 10.14309/ajg.0000000000001219
- 2021.03
- 의약학
-
Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B
- Gut First published November 25, 2020. | http://dx.doi.org/10.1136/gutjnl-2020-321309
- 2020.11
- 의약학
-
[Correspondence]Risk of Hepatocellular Carcinoma with Tenofovir vs. Entecavir in Patients with Chronic Hepatitis B
- Gastroenterology Published online: March 19, 2020 | https://doi.org/10.1053/j.gastro.2019.11.314
- 2020.06
- 의약학
